Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PONTE VEDRA, Fla., Feb. 8, 2024 /PRNewswire/ Cadrenal Therapeutics, Inc. , a biopharmaceutical company developing tecarfarin, a novel Vitamin K Antagonist for unmet needs in anticoagulation .
PONTE VEDRA, Fla., Jan. 24, 2024 /PRNewswire/ Cadrenal Therapeutics, Inc., , a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant designed to.
PONTE VEDRA, Fla., Jan. 4, 2024 /PRNewswire/ Cadrenal Therapeutics, Inc., , a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant designed to.